Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 27, 2017

DrugPatentWatch Database Preview

FLECAINIDE ACETATE Drug Profile

« Back to Dashboard

Which patents cover Flecainide Acetate, and what generic Flecainide Acetate alternatives are available?

Flecainide Acetate is a drug marketed by Aurobindo Pharma Ltd, Sun Pharm Inds Ltd, Idt Australia Ltd, Amneal Pharm, Apotex Inc, West-ward Pharms Int, and Ani Pharms Inc. and is included in seven NDAs.

The generic ingredient in FLECAINIDE ACETATE is flecainide acetate. There are nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the flecainide acetate profile page.

Summary for Tradename: FLECAINIDE ACETATE

Patents:0
Applicants:7
NDAs:7
Suppliers / Packagers: see list16
Bulk Api Vendors: see list30
Clinical Trials: see list448
Patent Applications: see list420
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FLECAINIDE ACETATE at DailyMed

Pharmacology for Tradename: FLECAINIDE ACETATE

Drug ClassAntiarrhythmic
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
FLECAINIDE ACETATE
flecainide acetate
TABLET;ORAL202821-001Jul 8, 2015ABRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
FLECAINIDE ACETATE
flecainide acetate
TABLET;ORAL076278-003Jan 14, 2003ABRXNoYes► Subscribe► Subscribe
Idt Australia Ltd
FLECAINIDE ACETATE
flecainide acetate
TABLET;ORAL076030-001Oct 28, 2002DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
FLECAINIDE ACETATE
flecainide acetate
TABLET;ORAL076421-001Mar 28, 2003ABRXNoNo► Subscribe► Subscribe
Amneal Pharm
FLECAINIDE ACETATE
flecainide acetate
TABLET;ORAL075442-003Jul 31, 2001ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot